Mangalam Drugs Ownership

MANGALAM   105.92  0.23  0.22%   
Mangalam Drugs And maintains a total of 15.83 Million outstanding shares. Mangalam Drugs And holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
2011-12-31
Previous Quarter
15.8 M
Current Value
15.8 M
Avarage Shares Outstanding
15.3 M
Quarterly Volatility
1.1 M
 
Yuan Drop
 
Covid
Some institutional investors establish a significant position in stocks such as Mangalam Drugs in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Mangalam Drugs, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mangalam Drugs And. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Mangalam Stock Ownership Analysis

About 55.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.13. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Mangalam Drugs And recorded a loss per share of 4.03. The entity last dividend was issued on the 21st of December 2017. The firm had 10:1 split on the 29th of November 2016. To find out more about Mangalam Drugs And contact the company at 91 22 6261 6200 or learn more at https://www.mangalamdrugs.com.

Mangalam Drugs Outstanding Bonds

Mangalam Drugs issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Mangalam Drugs And uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Mangalam bonds can be classified according to their maturity, which is the date when Mangalam Drugs And has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Mangalam Stock

Mangalam Drugs financial ratios help investors to determine whether Mangalam Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mangalam with respect to the benefits of owning Mangalam Drugs security.